Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC

Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)

NCT00173888 ·Status: COMPLETED ·Phase: PHASE2

Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.

NCT00425191 ·Status: COMPLETED ·Phase: PHASE2

Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

NCT00003037 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer

NCT00622349 ·Status: COMPLETED ·Phase: PHASE3

Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery

NCT00281970 ·Status: COMPLETED ·Phase: PHASE2

An Open, Randomized, Multicentre, Phase II Pilot Study

NCT00293085 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer

NCT00005868 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

NCT00263016 ·Status: TERMINATED ·Phase: PHASE2

Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00118131 ·Status: TERMINATED ·Phase: PHASE2

Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC

NCT00001450 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer

NCT00191256 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

NCT00258739 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel in Treating Patients With Non-Small Cell Lung Cancer

NCT00022022 ·Status: UNKNOWN ·Phase: PHASE3

Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

NCT00430651 ·Status: COMPLETED ·Phase: PHASE3

Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer

NCT00095199 ·Status: COMPLETED ·Phase: PHASE3

Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer

NCT02643407 ·Status: UNKNOWN ·Phase: PHASE3

Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00074204 ·Status: COMPLETED ·Phase: PHASE3

Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)

NCT00174772 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer

NCT00326378 ·Status: COMPLETED ·Phase: PHASE3

Tax First-line Chemotherapy With Different Doses and Then Maintenance Therapy

NCT01038661 ·Status: COMPLETED ·Phase: PHASE3

Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer

NCT01196234 ·Status: COMPLETED ·Phase: PHASE2

Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer

NCT02157116 ·Status: TERMINATED ·Phase: PHASE2

Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

NCT00082472 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy

NCT03371550 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

NCT00003762 ·Status: COMPLETED ·Phase: PHASE2